DelveInsight’s “Peanut Allergy Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Peanut Allergy market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Peanut Allergy market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Peanut Allergy: An Overview
As per the FDA, Peanut Allergy is a condition in which the body’s immune system does not recognize peanut protein and mistakenly identifies even tiny amounts of peanut as harmful. Allergic reactions to peanuts are unpredictable in occurrence and how they present, with some individuals experiencing severe reactions from even trace amounts. Anaphylaxis is the most common reaction in Peanut Allergy patients; it describes a severe and life-threatening allergic reaction.
It is observed that children with food allergies are more expected to have asthma or other allergic conditions. Nearly 90% of food allergies are caused by these common foods: tree nuts (almonds, walnuts, pecans, cashews, pistachios, etc.), peanuts, milk, eggs, fish, crustacean shellfish, wheat, and soy.
Palforzia (AR101) is the first FDA-approved oral immunotherapy for Peanut Allergy treatment. It is developed by Aimmune Therapeutics, and it is made up of carefully selected doses of peanut powder taken by mouth. It is designed for children and teens aged 4–17 with existing peanut allergies. The purpose is to desensitize children to peanuts.
Peanut Allergy Market Key Facts
The prevalent population of Peanut Allergy in the 7MM was estimated to be 10,578,500+ in 2020.
The market size of Peanut Allergy in the seven major markets was USD 360.8 million in 2020, which is expected to grow by 2032.
The current market for Peanut Allergy mainly consists of different formulations of immunotherapies, antihistamines, epinephrine, and other therapies such as self-injector. However, the treatment dynamics are anticipated to transform in the coming years owing to the launch of novel therapies.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Peanut Allergy market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the Peanut Allergy market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.
Peanut Allergy Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders.
Peanut Allergy Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Peanut Allergy market or expected to get launched during the study period. The analysis covers the Peanut Allergy market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Peanut Allergy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How Peanut Allergy Market Will Evolve by 2032 @
Some of the key companies in the Peanut Allergy Therapeutics Market include:
Nestle Health Sciences
And many others
Peanut Allergy Drugs Covered in the report include:
Viaskin Peanut/DBV712: DBV Technologies
Epicutaneous immunotherapy: EPIT
INP20: InnoUp Farma
ADP101: Alladapt Immunotherapeutics
And many more
Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More @
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Peanut Allergy Competitive Intelligence Analysis
4. Peanut Allergy Market Overview at a Glance
5. Peanut Allergy Disease Background and Overview
6. Peanut Allergy Patient Journey
7. Peanut Allergy Epidemiology and Patient Population (In the US, EU5, and Japan)
8. Peanut Allergy Treatment Algorithm, Current Treatment, and Medical Practices
9. Peanut Allergy Unmet Needs
10. Key Endpoints of Peanut Allergy Treatment
11. Peanut Allergy Marketed Products
12. Peanut Allergy Emerging Drugs and Latest Therapeutic Advances
13. Peanut Allergy Seven Major Market Analysis
14. Attribute Analysis
15. Peanut Allergy Market Outlook (In US, EU5, and Japan)
16. Peanut Allergy Access and Reimbursement Overview
17. KOL Views on the Peanut Allergy Market
18. Peanut Allergy Market Drivers
19. Peanut Allergy Market Barriers
21. DelveInsight Capabilities
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report @
Related Reports By DelveInsight
DelveInsight’s “Peanut Allergy Pipeline Insight” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Peanut Allergy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States